RVU.WA
Price:
$29.9
Market Cap:
$691.28M
Ryvu Therapeutics S.A., a clinical stage biopharmaceutical company, engages in developing of novel small molecule therapies for treatment in oncology. Its lead candidate, RVU120, is a CDK8 kinase inhibitor with potential for development in hematological malignancies and solid tumors, which is in Phase 1b study for the treatment of acute myeloid leukemia and myelodysplastic syndrome. The company's products also include SEL24/MEN1703, a dual PIM/FLT3 kinase inhibitor licensed to the Menarini Group that is in Phase 2 clinical trial for the treatment of acute myeloid leukemia. In addition, its early pipeline candidates include candidates in the area of kinases, cancer metabolism, synthetic letha...[Read more]
Industry
Biotechnology
IPO Date
2011-07-14
Stock Exchange
WSE
Ticker
RVU.WA
According to Ryvu Therapeutics S.A.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Ryvu Therapeutics S.A. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), RVU.WA's Dividend Yield was at its highest in in the September 2015 quarter at 0%. The Dividend Yield was at its lowest in in the September 2015 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Ryvu Therapeutics S.A. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
| 2018 | 0% | 0% |
| 2017 | 0% | 0% |
| 2016 | 0% | 0% |
| 2015 | 0% | 0% |
The current Dividend Yield of Ryvu Therapeutics S.A. (RVU.WA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Ryvu Therapeutics S.A.’s Dividend Yield is less than Bioceltix S.A. (0%), less than Captor Therapeutics Spolka Akcyjna (0%), less than Selvita S.A. (0%), less than Molecure S.A. (0%), less than Bioton S.a. (0%), less than Poltreg S.A. (0%), less than Centrum Medyczne ENEL-MED S.A. (0%), less than Scope Fluidics S.A. (0%), less than Mabion S.A. (0%), less than Synthaverse S.A. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $457.47M | |
| 0% | $403.57M | |
| 0% | $857.20M | |
| 0% | $150.20M | |
| 0% | $343.46M | |
| 0% | $116.59M | |
| 0% | $517.53M | |
| 0% | $402.89M | |
| 0% | $115.24M | |
| 0% | $264.00M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ryvu Therapeutics S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ryvu Therapeutics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Ryvu Therapeutics S.A.'s Dividend Yield?
How is the Dividend Yield calculated for Ryvu Therapeutics S.A. (RVU.WA)?
What is the highest Dividend Yield for Ryvu Therapeutics S.A. (RVU.WA)?
What is the 3-year average Dividend Yield for Ryvu Therapeutics S.A. (RVU.WA)?
What is the 5-year average Dividend Yield for Ryvu Therapeutics S.A. (RVU.WA)?
How does the current Dividend Yield for Ryvu Therapeutics S.A. (RVU.WA) compare to its historical average?